Page last updated: 2024-09-04

platycodin d and imatinib mesylate

platycodin d has been researched along with imatinib mesylate in 1 studies

Compound Research Comparison

Studies (platycodin d)	Trials (platycodin d)	Recent Studies (post-2010) (platycodin d)	Studies (imatinib mesylate)	Trials (imatinib mesylate)	Recent Studies (post-2010) (imatinib mesylate)
143	1	112	11,477	960	5,773

Protein Interaction Comparison

Protein	Taxonomy	platycodin d (IC50)	imatinib mesylate (IC50)
Tyrosine-protein kinase ABL1	Homo sapiens (human)		0.31
Mast/stem cell growth factor receptor Kit	Homo sapiens (human)		0.1

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dai, Q; Ge, YQ	1

Other Studies

1 other study(ies) available for platycodin d and imatinib mesylate

Article	Year
[Inhibitory effect and mechanism of platycodin D combined with imatinib on K562/R]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2018, Volume: 43, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Saponins; Signal Transduction; Triterpenes	2018

Article

Year

[Inhibitory effect and mechanism of platycodin D combined with imatinib on K562/R].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2018, Volume: 43, Issue:2

Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Saponins; Signal Transduction; Triterpenes

2018